Research Grants

Grant applications are called for across programs relating to all aspects of; basic research, clinical trials, translational studies, diagnosis, and clinical care of juvenile myositis. A pertinent but not exhaustive list of priorities includes:

• Conducting analyses on samples and/or data available from innovative treatment clinical studies.
• Collaboration with pharmaceutical companies or other research organizations that are developing new therapies that may have utility in the treatment of juvenile myositis. The collaboration may comprise the generation of clinical protocols for new treatments and a defined route to funding a clinical study. Such proposals should include solid evidence of access to the therapy being proposed for investigation.
• Clinical protocols for repurposed drugs for the treatment of juvenile myositis. Such proposals should include solid evidence of access to the therapy being proposed for investigation and a defined route to funding a clinical study.
• Investigations of in vitro or in vivo models of juvenile myositis with the objective of the development of new therapies.
• Novel diagnostic strategies, including the development of biomarkers.
• All aspects of clinical care, spanning mental health and consensus treatment protocols